Gastrointestinal side effect profile due to the use of alendronate in the treatment of osteoporosis

Creative Commons License

Aki S., Eskiyurt N., Akarirmak U., Tuzun F., Eryavuz M., Alper S., ...More

YONSEI MEDICAL JOURNAL, vol.44, no.6, pp.961-967, 2003 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 44 Issue: 6
  • Publication Date: 2003
  • Doi Number: 10.3349/ymj.2003.44.6.961
  • Journal Name: YONSEI MEDICAL JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.961-967
  • Kütahya Health Sciences University Affiliated: No

Abstract

The aim of our study was to evaluate the upper gastrointestinal (GI) tract side effect profile in 759 female patients that had taken alendronate (10 mg/day), for at least 6 months, for the treatment of osteoporosis, in relation to the safety of alendronate and the compliance of patients to its absorption rules.